Summary of Key Points Core Viewpoint - The A-share and Hong Kong stock markets have seen a concentration of new listings, with significant first-day gains for newly listed companies, indicating strong investor interest and market resilience. Group 1: IPO Approvals - Three companies have received IPO approvals this week, all from the Beijing Stock Exchange [2] - Zhejiang Hengdao Technology Co., Ltd. specializes in the research, design, production, and sales of hot runner systems for injection molds, with a major focus on automotive and consumer electronics sectors [3] - Hebi Haichang Intelligent Technology Co., Ltd. focuses on high-performance wiring harness equipment, serving industries such as automotive and renewable energy [5] - Kunshan Hongshida Intelligent Technology Co., Ltd. is engaged in the development and production of intelligent automation equipment for various sectors, including consumer electronics and new energy [6] Group 2: Financial Performance - Hengdao Technology's revenue for 2022-2024 is projected to be 143 million, 168 million, and 234 million yuan, with net profits of 39 million, 49 million, and 69 million yuan respectively [4] - Haichang Intelligent's revenue for the same period is expected to be 520 million, 652 million, and 800 million yuan, with net profits of 108 million, 121 million, and 115 million yuan [5] - Hongshida's revenue is projected to be 397 million, 476 million, and 649 million yuan, with net profits of 30 million, 39 million, and 53 million yuan [7] Group 3: New Listings - "Mingming Hen Mang" (01768.HK), the first stock in the snack retail sector, debuted on January 28, with a first-day closing price increase of 77.52% [9] - Agricultural Technology Company (831038.BJ) listed on the Beijing Stock Exchange, with a first-day closing increase of 1.19% [9] - Zhenstone Co., Ltd. (601112.SH), a leader in clean energy materials, saw its stock price surge by 121.65% on its first day of trading [10] - Medical device company Medela (920119.BJ) also experienced a significant first-day increase of 161.46% [10] Group 4: Filing Dynamics - Eleven companies filed for IPOs in the Hong Kong market this week, with a focus on A+H share expansion [11] - Notable filings include Jucheng Co., a leading non-volatile memory chip designer, and Deyang Co., a leader in energy storage [11] - The trend shows a concentration of hard technology companies seeking to leverage their A-share listings for international financing [12] Group 5: Sector Highlights - Hard technology companies are prominent in the recent IPO filings, with firms like Kunlun New Energy Materials and Coolchip Microelectronics focusing on core material development and AI solutions [12] - Consumer and medical sectors are also active, with companies like Tongrentang and Zhuozheng Medical seeking to expand their service capabilities and market presence [13]

Core Viewpoint - The situation regarding NVIDIA's chip supply to China has dramatically changed, with the H200 orders initially expected to be plentiful now facing uncertainty and potential restrictions [1][4]. Group 1: NVIDIA's Chip Supply Dynamics - Prior to the H200, NVIDIA's only chip available for China was the H20, which was a downgraded version and deemed obsolete globally [1]. - The U.S. government's restrictions led to NVIDIA's market share in China plummeting from 95% to 0%, resulting in zero orders and revenue [1]. - Despite the initial expectation of high demand for the H200, NVIDIA's CEO has reported no orders from Chinese companies for this chip [4]. Group 2: U.S. Government's Position - CEO Jensen Huang has warned that U.S. restrictions will ultimately harm American companies and may accelerate China's domestic chip development [2]. - The U.S. government, particularly under Trump, has allowed the export of H200 to China, but with a condition of a 25% revenue share from NVIDIA's operations in China [4]. - There is internal conflict within the U.S. government regarding the approval of H200 exports, leading to uncertainty in the supply chain [4]. Group 3: China's Response and Strategy - China has prioritized the use of domestic chips, indicating that American chips are no longer essential [7]. - The current dynamics suggest that China now has the power to decide whether to purchase American chips, reversing the previous dependency [8]. - Regardless of U.S. policy changes, China's commitment to self-reliance in chip development remains strong, with no intention to slow down domestic innovation [10].

Group 1: Investment Strategy - The investment strategy for 2026 focuses on cyclical recovery in sectors like engineering machinery, industrial gases, and shipping[1] - Growth sectors include embodied intelligence, controllable nuclear fusion, photovoltaic equipment, lithium battery equipment, semiconductor equipment, AIDC, and PCB equipment[1] - Optimism towards the U.S. market strategy due to easing trade disputes and potential Federal Reserve interest rate cuts[1] Group 2: Engineering Machinery Market - The global engineering machinery market is projected to reach $213.5 billion in 2024, with a CAGR of 6% from 2024 to 2030[2] - Domestic excavator sales are expected to grow by 18% in 2025, reaching 118,518 units, while total excavator sales will increase by 17% to 235,257 units[2] - China's leading manufacturers are gaining global market share, with SANY's market value at approximately 10% of Caterpillar's as of January 2026[3] Group 3: Industrial Gases - The industrial gas market is expected to reach ¥1.3 trillion in 2026, with a CAGR of 6.8% over the next four years[19] - The competitive landscape is concentrated, with the top four global industrial gas companies holding a 54% market share[19] - Growth drivers include macroeconomic recovery and increased demand from sectors like semiconductors and renewable energy[19] Group 4: Semiconductor Equipment - The global semiconductor market is expected to grow by 9% in 2026, reaching $760.7 billion, driven by AI demand[14] - Domestic semiconductor equipment demand is expected to rise due to increased production capacity and a focus on self-sufficiency[14] - Key investment areas include etching and thin-film equipment, as well as the domestic production of photolithography machines[15]

Investment Rating - The investment rating for the optical chip industry is "Positive" and maintained [11] Core Viewpoints - Optical chips are a high-value segment within the optical communication industry, characterized by significant technical barriers and value [3][9] - The industry predominantly adopts the IDM model, which covers the entire process from design to manufacturing and testing, leading to high entry barriers [7][50] - Domestic optical chip manufacturers are expected to benefit from a combination of industry growth, structural opportunities in silicon photonics, and increased market share from domestic replacements [8][9] Summary by Sections Optical Chips - Optical chips are the core active components in optical communication, determining the quality, speed, and energy efficiency of optical signal transmission [6][21] - The transition from traditional discrete solutions to high-integration silicon photonics solutions is accelerating, driven by the limitations of existing technologies [6][36] Manufacturers of Optical Chips - Manufacturers typically use the IDM model, which enhances collaboration with downstream module manufacturers and allows for rapid iteration and optimization of processes [7][50] - The industry faces significant barriers in R&D iteration, process yield, and capacity expansion, with domestic manufacturers focusing on the CW light source route due to its shorter production chain and better yield optimization [7][9] AI and Connectivity Demand - The demand for optical chips is expected to rise due to the commercialization of AI by North American cloud providers, leading to increased capital expenditures and a positive feedback loop in computing power investments [8][9] - The supply side is constrained by a concentrated upstream InP substrate market and long expansion cycles, with a predicted 25%-30% shortfall in optical chips [8] Investment Recommendations - The report recommends focusing on leading domestic CW light source manufacturers, particularly Shijia Photon, and paying attention to Yuanjie Technology [9][12]

Core Viewpoint - Jucheng Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, initiating a dual listing strategy, and is recognized as a leading player in the domestic non-volatile memory (NVM) chip sector, achieving significant breakthroughs in various niche markets [1]. Group 1: Company Overview - Founded in November 2009, Jucheng Co., Ltd. has over a decade of experience in chip design, focusing on the demand for storage and mixed-signal chips in the AI era, and has developed a diversified product matrix including SPD chips, EEPROM, NOR Flash, and camera motor driver chips [4]. - The company is actively promoting the mass production of closed-loop and optical image stabilization motor driver chips, which have passed tests by major smartphone manufacturers and are expected to be used in mid-to-high-end and flagship models [4]. - Jucheng's products are widely used in AI infrastructure, automotive electronics, industrial control, and consumer electronics, establishing strong partnerships with global memory module giants and well-known automotive and smartphone manufacturers such as Samsung, Huawei, Xiaomi, BYD, and Tesla [4]. Group 2: Market Position and Performance - According to Frost & Sullivan data, Jucheng Co., Ltd. ranks as the third-largest EEPROM supplier globally and the largest in China, while also being the second-largest supplier of DDR5 SPD chips, holding over 40% of the global market share for DDR5 SPD chips [5]. - The company has achieved a 14.0% market share in the global EEPROM market, with a leading position in the camera module EEPROM market at 40.3% and 21.8% in the liquid crystal panel EEPROM market [5]. - In the automotive electronics sector, Jucheng has become a key player in domestic automotive-grade chips, expected to be the only supplier of a full range of automotive-grade EEPROM chips in China by the end of 2025, and ranks as the third-largest globally [6]. Group 3: Financial Performance - Jucheng Co., Ltd. has shown steady improvement in profitability, with projected revenues of 1.028 billion yuan and a net profit of 290 million yuan for 2024, marking a 43.50% year-on-year increase in net profit for the first half of 2025 [8]. - The company's market capitalization reached 29.47 billion yuan as of January 30, 2026, reflecting growing recognition in the capital market [8]. Group 4: Future Outlook - Jucheng Co., Ltd. aims to leverage its technological advantages and comprehensive product offerings to strengthen its leading position in existing niche markets, expand into high-value sectors such as automotive electronics and industrial control, and capitalize on the increasing penetration of DDR5 and the explosive growth of AI computing power [10].

Core Insights - The ECMO market in China is undergoing a significant transformation, moving from foreign brand dominance to a surge in domestic alternatives driven by policy support, technological advancements, and increasing clinical demand [1][2][8] - The market size for ECMO in China is projected to reach 960 million yuan in 2024, growing to 3.71 billion yuan by 2030, with a compound annual growth rate of 25.2% from 2024 to 2030 [1][2] - The current ECMO penetration rate in China is low, with only one device per 280 million people, indicating substantial growth potential [1] Market Restructuring - Historically, foreign brands like Maquet, Medtronic, and Fresenius Kabi have controlled approximately 70% of the ECMO market, leading to high procurement costs for domestic medical institutions [2][3] - The price of foreign ECMO devices ranges from 1.5 million to 3 million yuan, with some high-end models costing up to 8 million yuan, creating a significant cost burden [2] - Recent policy changes, including the "Healthy China 2030" initiative and revised medical device regulations, have facilitated the entry of domestic companies into the market [2][3] Domestic Market Growth - Domestic ECMO devices are priced between 1.035 million and 1.5 million yuan, approximately 30% lower than imported devices, leading to a steady increase in market share [3] - By mid-2025, domestic ECMO devices are expected to capture over 30% of the market, with projections of reaching 35% by the end of 2025 [3] - Companies like Hanno Medical, Changzheng Medical, and Saiteng Medical are emerging as key players in the domestic market, with Changzheng Medical reporting significant sales and market presence [3][4] Technological Advancements - Changzheng Medical leverages technology from the China Aerospace Science and Technology Corporation, applying advanced control and simulation techniques to develop competitive ECMO products [4] - The market is shifting from a focus on individual device sales to comprehensive solutions that include equipment, consumables, and services [4] - The rise of third-party medical equipment leasing companies, which hold 20% of the market share, is providing flexible solutions for smaller hospitals [4] Challenges and Pain Points - Despite the growth opportunities, challenges such as reliance on imported components, high costs, and insufficient insurance coverage hinder the widespread adoption of ECMO technology [5][6] - The cost of a single ECMO treatment can reach 100,000 to 200,000 yuan, with consumables accounting for over 60% of the total cost, and many regions do not fully reimburse ECMO treatments [5] - The lack of standardized efficacy evaluation and varying treatment levels across institutions further complicates the market landscape [5][6] Policy and Future Outlook - Ongoing improvements in insurance policies are gradually incorporating ECMO treatments into reimbursement frameworks, which is expected to alleviate patient financial burdens and enhance treatment efficiency [7] - The application of ECMO is primarily in tertiary hospitals' intensive care and cardiac surgery departments, but advancements in technology and training are expected to broaden its use across various medical fields [7][8] - The push for better healthcare infrastructure in lower-tier hospitals, supported by government policies, is likely to expand the market for ECMO technology [8] - The ECMO industry is at a critical juncture, where overcoming core technological challenges and optimizing cost structures will be essential for achieving sustainable development and making ECMO a more accessible medical technology [8]

Company Overview - Stada Semiconductor Co., Ltd. was established on April 27, 2005, and is headquartered in Jiaxing, Zhejiang Province. The company specializes in the design, research and development, production, and sales of semiconductor chips and modules, primarily focusing on IGBT technology. Its products cover IGBT, SiC, GaN, and MCU chips and modules, with voltage levels ranging from 100V to 3300V and current levels from 10A to 3600A, widely used in sectors such as new energy vehicles, industrial control, photovoltaics, energy storage, and home appliances [2] Financial Performance - As of the first three quarters of 2025, the company achieved operating revenue of 2.99 billion yuan, a year-on-year increase of 23.82%. However, the net profit attributable to shareholders decreased by 9.80% to 382 million yuan, with a non-recurring net profit decline of 11.58%. The revenue growth was primarily driven by high-demand sectors such as new energy vehicles and AI servers, while net profit was pressured by a significant increase in R&D expenses, which reached 344 million yuan, accounting for 11.5% of operating revenue. The third quarter of 2025 saw a single-quarter revenue of 1.05 billion yuan, indicating a significant quarter-on-quarter growth [3] Fundraising Projects - The company plans to raise up to 1.5 billion yuan through the issuance of convertible bonds for three major manufacturing projects and to supplement working capital. The specific projects include: - Automotive-grade SiC MOSFET module manufacturing project: 600 million yuan investment, expected annual production capacity of 2.8 million units, projected annual sales revenue of 1.8 billion yuan, with an internal rate of return of 18.45% - IPM module manufacturing project: 270 million yuan investment, expected annual production capacity of 30 million units, projected annual sales revenue of 660 million yuan, with an internal rate of return of 16.00% - Automotive-grade GaN module industrialization project: 200 million yuan investment, expected annual production capacity of 1 million units, projected annual sales revenue of 451 million yuan, with an internal rate of return of 18.73% - Supplementing working capital: 430 million yuan [4] Major Clients - The company's core clients are concentrated in the new energy vehicle, industrial control, and power supply sectors. From 2015 to 2019, major clients included Shanghai Electric Drive, Shenzhen Inovance Technology, and Hefei Juyi Power Systems. Recently, the company has deepened cooperation with leading Tier 1 suppliers in Europe, with products entering the supply chains of several international mainstream automotive manufacturers. In 2024, the company has begun sampling for leading global server power supply manufacturers and is actively expanding into the AI server 800V HVDC power supply market, indicating a shift in client structure from traditional industrial control to high-end automotive and AI scenarios [6] Industry Landscape - The power semiconductor market is expanding, driven by high-growth sectors such as new energy vehicles, AI servers, photovoltaics, and industrial automation. Automotive-grade SiC MOSFETs are rapidly replacing traditional IGBTs due to their high-temperature and high-efficiency characteristics. The adoption of 800V high-voltage direct current power supply architecture in AI data centers is further driving the demand for GaN and SiC devices. As of January 30, 2026, the total market value of the semiconductor discrete device industry reached 466.76 billion yuan, with Stada Semiconductor being a leading player in the IGBT/SiC module sector, holding a market value of 26.49 billion yuan, accounting for approximately 5.7% of the industry. The company is expected to achieve a 30% cost reduction and a gross margin increase to over 50% by establishing a 6-inch SiC production line and planning an 8-inch production line, further solidifying its industry-leading position [9]

Company Overview - Stada Semiconductor Co., Ltd. was established on April 27, 2005, and is headquartered in Jiaxing, Zhejiang Province. The company specializes in the design, research and development, production, and sales of semiconductor chips and modules, primarily focusing on IGBT technology. Its products include IGBT, SiC, GaN, and MCU chips and modules, with voltage levels ranging from 100V to 3300V and current levels from 10A to 3600A, widely used in sectors such as new energy vehicles, industrial control, photovoltaics, energy storage, and home appliances [1] Financial Performance - As of the first three quarters of 2025, the company achieved operating revenue of 2.99 billion yuan, a year-on-year increase of 23.82%. However, the net profit attributable to shareholders decreased by 9.80% to 382 million yuan, with a non-recurring net profit decline of 11.58%. The revenue growth was primarily driven by high-demand sectors such as new energy vehicles and AI servers, while net profit was pressured by a significant increase in R&D expenses, which reached 344 million yuan, accounting for 11.5% of operating revenue. In Q3 2025, the single-quarter revenue reached 1.05 billion yuan, showing a significant quarter-on-quarter growth, indicating a continuous recovery in revenue [2] Fundraising Projects - The company plans to raise up to 1.5 billion yuan through the issuance of convertible bonds for three major manufacturing projects and to supplement working capital. The specific projects include: - Automotive-grade SiC MOSFET module manufacturing project: 600 million yuan investment, expected annual production capacity of 2.8 million units, projected annual sales revenue of 1.8 billion yuan, with an internal rate of return of 18.45% - IPM module manufacturing project: 270 million yuan investment, expected annual production capacity of 30 million units, projected annual sales revenue of 660 million yuan, with an internal rate of return of 16.00% - Automotive-grade GaN module industrialization project: 200 million yuan investment, expected annual production capacity of 1 million units, projected annual sales revenue of 451 million yuan, with an internal rate of return of 18.73% - Supplementing working capital: 430 million yuan [3] Major Clients - The company's core clients are concentrated in the new energy vehicle, industrial control, and power supply sectors. From 2015 to 2019, major clients included leading domestic motor controller and inverter manufacturers such as Shanghai Electric Drive, Shenzhen Inovance Technology, and Hefei Juyi Power Systems. In recent years, the company has deepened cooperation with top-tier European suppliers, with products entering the supply chains of several international mainstream automotive manufacturers. By 2024, the company has begun sampling for leading global server power supply manufacturers and is actively expanding into the AI server 800V HVDC power supply market, indicating a shift in client structure from traditional industrial control to high-end automotive and AI scenarios [5] Industry Landscape - The power semiconductor sector is a core component of power electronic systems, benefiting from high-growth areas such as new energy vehicles, AI servers, photovoltaics, and industrial automation. The market space is continuously expanding. Automotive-grade SiC MOSFETs are rapidly replacing traditional IGBTs due to their high-temperature and high-efficiency characteristics, with increasing penetration rates. The adoption of 800V high-voltage direct current power supply architecture in AI data centers further drives the demand for GaN and SiC devices. As of January 30, 2026, the total market value of the semiconductor discrete device industry reached 466.76 billion yuan, with Stada Semiconductor, as a leading domestic IGBT/SiC module manufacturer, having a market value of 26.49 billion yuan, accounting for approximately 5.7% of the industry. The company is expected to achieve a 30% cost reduction and a gross margin increase to over 50% by establishing a 6-inch SiC production line and planning an 8-inch production line, further solidifying its leading position in the industry [7]

Market Overview - The A-share market experienced a significant decline, with the Shanghai Composite Index breaking below the 5-day and 10-day moving averages, indicating increased bearish momentum [6] - A total of 2,449 stocks rose, while the decline-to-rise ratio was 59:61, reflecting a mixed market sentiment with localized recovery in profitability [7] - The main funds saw a net outflow of 4.868 billion yuan, indicating a shift in investor sentiment [8] Trading Volume and Sentiment - The total trading volume of the two markets was 0.84 trillion yuan, down 12.21%, showing a notable decrease in trading activity and a prevailing cautious sentiment among investors [9] - Institutional investors are primarily focusing on portfolio adjustments and structural optimization, moving away from defensive sectors to growth sectors like CPO, semiconductors, and agriculture [11] Investor Behavior - Retail investors are showing rational behavior, avoiding short-term volatility risks while selectively investing in quality stocks during sector rotations [11] - The sentiment among retail investors indicates a preference for strategic positioning rather than impulsive trading, with a notable portion of funds being allocated to high-potential sectors [11]

Investment Rating - The report gives a positive investment rating for Aide Technology, highlighting its leadership in orthopedic consumables and the dual opportunities presented by aging population and domestic substitution [1]. Core Viewpoints - Aide Technology focuses on the research, production, and sales of orthopedic medical devices, covering spinal, trauma, joint, and sports medicine fields, with a projected 13.76% increase in net profit attributable to shareholders in 2025 [1][10]. - The company ranks third in the domestic market for spinal vertebroplasty systems and sixth for spinal implant medical devices, indicating a strong market position [1][11]. - The orthopedic medical device market in China is expected to grow from 193 billion yuan in 2016 to 246 billion yuan in 2024, with a compound annual growth rate (CAGR) of 3.08% [2][9]. Company Overview - Aide Technology is a national high-tech enterprise with various accolades, including recognition as a "specialized and innovative small and medium-sized enterprise" in Jiangsu Province [1][11]. - The company has developed a comprehensive product line that includes vertebroplasty systems, trauma implants, and wound healing products, with a focus on clinical needs [10][15]. - As of November 24, 2025, Aide Technology holds 110 patents, including 45 invention patents, and has established a strong technical advantage in its niche markets [11][12]. Financial Performance - For the first three quarters of 2025, the company reported revenues of 222.69 million yuan and a net profit of 59.55 million yuan, with forecasts for 2025 showing revenues of 307.48 million yuan and net profits of 76.37 million yuan [1][2]. - The company’s gross profit margins have shown slight fluctuations, with rates of 62.45%, 57.80%, 58.05%, and 58.89% from 2022 to the first half of 2025 [7][12]. Industry Insights - The report notes that the trend of centralized procurement in the orthopedic industry is stabilizing, reducing the likelihood of further significant price drops [2][9]. - The orthopedic implant market has seen a decline in 2022-2023 due to centralized procurement policies, but opportunities remain in non-procurement products and overseas markets [2][9]. - The aging population in China is expected to drive demand for orthopedic products, as the incidence of related diseases increases [2][9].